Key result
Cardiac metastasis from cervical cancer carries a poor prognosis, yielding median survival of ~3 months.
Why the study?
Ante-mortem diagnosed metastatic pericardial effusion in cervical cancer patients is very rare, and clinical data on presentation, diagnosis, and treatment are limited.
Systematic Review (n=87)
Answers are grounded in this paper and cite their sources.
Alerts clinicians to rare cardiac metastases in cervical cancer; leaves open optimal management beyond case reports.
Ante-mortem diagnosed metastatic pericardial effusion in cervical cancer patients is very rare. Symptomatic relief and treatment of the underlying disease offered by a multidisciplinary team, may prolong survival with a good quality of life to these often young patients.
No takes yet. Share an insight, caveat, or question.
Verleye et al. (2009) conducted a systematic review in Cardiac metastasis from cervical cancer (n=87). Cardiac metastasis was evaluated on Median survival time after diagnosis of cardiac metastasis. Cardiac metastasis from cervical cancer is exceptionally rare and associated with a very poor prognosis, yielding an overall median survival time of 3 months.
Synapse has enriched 10 related papers. Consider them for comparative context: